Hypertensive Disorders of Pregnancy
Am Fam Physician. 2024 Mar;109(3):251-260.ABSTRACTHypertensive disorders of pregnancy are a major contributor to maternal morbidity and mortality in the United States and include chronic and gestational hypertension, preeclampsia, HELLP (hemolysis, elevated liver enzymes, and low platelet count) syndrome, eclampsia, and chronic hypertension with superimposed preeclampsia. For patients with chronic hypertension, oral antihypertensive therapy should be initiated or titrated at a blood pressure threshold of 140/90 mm Hg or greater. Gestational hypertension and preeclampsia without severe features can be managed with blood pre...
Source: American Family Physician - April 4, 2024 Category: Primary Care Authors: Narges Farahi Fareedat Oluyadi Andrea B Dotson Source Type: research
Hypertensive Disorders of Pregnancy
Am Fam Physician. 2024 Mar;109(3):251-260.ABSTRACTHypertensive disorders of pregnancy are a major contributor to maternal morbidity and mortality in the United States and include chronic and gestational hypertension, preeclampsia, HELLP (hemolysis, elevated liver enzymes, and low platelet count) syndrome, eclampsia, and chronic hypertension with superimposed preeclampsia. For patients with chronic hypertension, oral antihypertensive therapy should be initiated or titrated at a blood pressure threshold of 140/90 mm Hg or greater. Gestational hypertension and preeclampsia without severe features can be managed with blood pre...
Source: American Family Physician - April 4, 2024 Category: Primary Care Authors: Narges Farahi Fareedat Oluyadi Andrea B Dotson Source Type: research
Hypertensive Disorders of Pregnancy
Am Fam Physician. 2024 Mar;109(3):251-260.ABSTRACTHypertensive disorders of pregnancy are a major contributor to maternal morbidity and mortality in the United States and include chronic and gestational hypertension, preeclampsia, HELLP (hemolysis, elevated liver enzymes, and low platelet count) syndrome, eclampsia, and chronic hypertension with superimposed preeclampsia. For patients with chronic hypertension, oral antihypertensive therapy should be initiated or titrated at a blood pressure threshold of 140/90 mm Hg or greater. Gestational hypertension and preeclampsia without severe features can be managed with blood pre...
Source: American Family Physician - April 4, 2024 Category: Primary Care Authors: Narges Farahi Fareedat Oluyadi Andrea B Dotson Source Type: research
Hypertensive Disorders of Pregnancy
Am Fam Physician. 2024 Mar;109(3):251-260.ABSTRACTHypertensive disorders of pregnancy are a major contributor to maternal morbidity and mortality in the United States and include chronic and gestational hypertension, preeclampsia, HELLP (hemolysis, elevated liver enzymes, and low platelet count) syndrome, eclampsia, and chronic hypertension with superimposed preeclampsia. For patients with chronic hypertension, oral antihypertensive therapy should be initiated or titrated at a blood pressure threshold of 140/90 mm Hg or greater. Gestational hypertension and preeclampsia without severe features can be managed with blood pre...
Source: American Family Physician - April 4, 2024 Category: Primary Care Authors: Narges Farahi Fareedat Oluyadi Andrea B Dotson Source Type: research
Dual-pathway Inhibition with Low-dose Aspirin and Rivaroxaban versus Aspirin Monotherapy in Patients with Coronary Artery Disease and Peripheral Artery Disease: Systematic Literature Review and Meta-analysis
Platelet activation and aggregation play a pivotal role in the complex pathophysiological process of atherosclerotic disease, resulting in the formation of an occlusive thrombus.1 Furthermore, platelets modulate the various endothelial and inflammatory processes tha...
Dual-pathway Inhibition with Low-dose Aspirin and Rivaroxaban versus Aspirin Monotherapy in Patients with Coronary Artery Disease and Peripheral Artery Disease: Systematic Literature Review and Meta-analysis
Platelet activation and aggregation play a pivotal role in the complex pathophysiological process of atherosclerotic disea...
Source: Radcliffe Cardiology - April 4, 2024 Category: Cardiology Authors: dbarot525787 Source Type: research
Clinical study of tirofiban compared to low molecular weight heparin in the antithrombotic treatment of progressive pontine infarction
CONCLUSIONS: Tirofiban may be more effective and safer than LMWH in controlling the progression of acute pontine infarction, but further and large-sample studies are still needed to confirm this finding.PMID:38567581 | DOI:10.26355/eurrev_202403_35722 (Source: Pharmacological Reviews)
Source: Pharmacological Reviews - April 3, 2024 Category: Drugs & Pharmacology Authors: Q Zhou L-E Xu L-L Lin X-R Huang W-Z Chi J Lin P Lin Source Type: research
Clinical study of tirofiban compared to low molecular weight heparin in the antithrombotic treatment of progressive pontine infarction
CONCLUSIONS: Tirofiban may be more effective and safer than LMWH in controlling the progression of acute pontine infarction, but further and large-sample studies are still needed to confirm this finding.PMID:38567581 | DOI:10.26355/eurrev_202403_35722 (Source: European Review for Medical and Pharmacological Sciences)
Source: European Review for Medical and Pharmacological Sciences - April 3, 2024 Category: Drugs & Pharmacology Authors: Q Zhou L-E Xu L-L Lin X-R Huang W-Z Chi J Lin P Lin Source Type: research
Clinical study of tirofiban compared to low molecular weight heparin in the antithrombotic treatment of progressive pontine infarction
CONCLUSIONS: Tirofiban may be more effective and safer than LMWH in controlling the progression of acute pontine infarction, but further and large-sample studies are still needed to confirm this finding.PMID:38567581 | DOI:10.26355/eurrev_202403_35722 (Source: Pharmacological Reviews)
Source: Pharmacological Reviews - April 3, 2024 Category: Drugs & Pharmacology Authors: Q Zhou L-E Xu L-L Lin X-R Huang W-Z Chi J Lin P Lin Source Type: research
Clinical study of tirofiban compared to low molecular weight heparin in the antithrombotic treatment of progressive pontine infarction
CONCLUSIONS: Tirofiban may be more effective and safer than LMWH in controlling the progression of acute pontine infarction, but further and large-sample studies are still needed to confirm this finding.PMID:38567581 | DOI:10.26355/eurrev_202403_35722 (Source: European Review for Medical and Pharmacological Sciences)
Source: European Review for Medical and Pharmacological Sciences - April 3, 2024 Category: Drugs & Pharmacology Authors: Q Zhou L-E Xu L-L Lin X-R Huang W-Z Chi J Lin P Lin Source Type: research
